Manulife (Manufacturers Life Insurance)
PCVX icon

Manulife (Manufacturers Life Insurance)’s Vaxcyte PCVX Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.02M Sell
86,366
-22,079
-20% -$1.2M ﹤0.01% 1161
2025
Q4 		$4.97M Sell
108,445
-28,425
-21% -$1.27M ﹤0.01% 1169
2025
Q3 		$4.93M Sell
136,870
-71,140
-34% -$2.36M ﹤0.01% 1178
2025
Q2 		$6.76M Buy
208,010
+54,858
+36% +$1.8M 0.01% 1026
2025
Q1 		$5.78M Sell
153,152
-5,376
-3% -$430K 0.01% 1109
2024
Q4 		$13M Buy
158,528
+1,504
+1% +$149K 0.01% 761
2024
Q3 		$17.9M Buy
157,024
+25,275
+19% +$2.28M 0.02% 665
2024
Q2 		$9.95M Buy
131,749
+12,667
+11% +$862K 0.01% 843
2024
Q1 		$8.13M Buy
119,082
+14,009
+13% +$970K 0.01% 957
2023
Q4 		$6.6M Buy
105,073
+12,249
+13% +$636K ﹤0.01% 1041
2023
Q3 		$4.73M Buy
92,824
+11,135
+14% +$549K ﹤0.01% 1139
2023
Q2 		$4.08M Buy
81,689
+52,729
+182% +$2.5M ﹤0.01% 1185
2023
Q1 		$1.09M Buy
28,960
+463
+2% +$19.6K ﹤0.01% 1596
2022
Q4 		$1.37M Buy
28,497
+7,754
+37% +$304K ﹤0.01% 1490
2022
Q3 		$498K Sell
20,743
-13
-0.1% -$330 ﹤0.01% 1975
2022
Q2 		$452K Buy
20,756
+3,247
+19% +$75.1K ﹤0.01% 2118
2022
Q1 		$423K Sell
17,509
-3,971
-18% -$86.8K ﹤0.01% 2296
2021
Q4 		$511 Buy
21,480
+101
+0.5% +$2.35K ﹤0.01% 2241
2021
Q3 		$542K Sell
21,379
-1,509
-7% -$36.6K ﹤0.01% 2230
2021
Q2 		$515K Buy
22,888
+6,249
+38% +$128K ﹤0.01% 2405
2021
Q1 		$329K Buy
16,639
+5,379
+48% +$135K ﹤0.01% 2555
2020
Q4 		$299K Buy
11,260
+1,297
+13% +$48.2K ﹤0.01% 2520
2020
Q3 		$492K Buy
+9,963
New +$397K ﹤0.01% 2010

Other funds holding PCVX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s PCVX Position: Q1 2026 in Review

Manulife (Manufacturers Life Insurance) reduced its Vaxcyte (PCVX) stake by 20% in Q1 2026, selling an estimated $1.2M and leaving 86,366 shares worth $5.02M. The position accounts for ﹤0.01% of the portfolio, ranked #1161.

Manulife (Manufacturers Life Insurance) first reported a position in PCVX in Q3 2020 and has held it in 23 quarters since. The position peaked at $17.9M in Q3 2024. 336 funds tracked by Wall St. Rank hold PCVX as of Q1 2026.

  • Manulife (Manufacturers Life Insurance) held 86,366 shares of Vaxcyte worth $5.02M as of Q1 2026.
  • Manulife (Manufacturers Life Insurance) sold 22,079 Vaxcyte shares in Q1 2026, an estimated $1.2M.
  • Vaxcyte made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q1 2026, its #1161 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in Vaxcyte in Q3 2020 and has held it in 23 quarters since.
  • Manulife (Manufacturers Life Insurance)'s Vaxcyte position peaked at $17.9M in Q3 2024.
  • 336 funds tracked by Wall St. Rank held Vaxcyte as of Q1 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.